LGND

Ligand Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality6/10
  • Growth↑ 8/10
  • Value↓ 1/10
Ligand Pharmaceuticals sales and earnings growth
LGND Growth
Good
  • Revenue Y/Y↑ 60.40%
  • EPS Y/Y↑ 3027.27%
  • FCF Y/Y↓ -49.49%
Ligand Pharmaceuticals gross and profit margin trends
LGND Profitability
Great
  • Gross margin ↑ 94.60%
  • EPS margin↑ 46.40%
  • ROIC 5Y↑ 11.73%
Ligand Pharmaceuticals net debt vs free cash flow
LGND Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↑ 5.8
  • Interest coverage↑ 34.7

Ligand Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks